Impact Highlight Timeline
Notable highlights from 2022.
$6.3 million Awarded to evaluate effectiveness of fractional doses of COVID-19 vaccine
Sabin was awarded up to $6.3 million from the Coalition for Epidemic Preparedness Innovations (CEPI) for a clinical trial to evaluate the immunogenicity and safety of lower, fractional doses of registered COVID-19 vaccines used as a booster dose. This dose optimizing trial will allow us to understand if smaller doses of COVID-19 vaccines generate similar immune responses to full doses. It will also provide key information as to whether lower doses may have fewer side effects, potentially increasing vaccine acceptance.
Anuradha Gupta Joins Sabin as President of Global Immunization
Veteran public health leader Anuradha Gupta, who spearheaded a host of successful global initiatives to improve the health of women and children and boost vaccine access and uptake, has joined Sabin Vaccine Institute as President of Global Immunization.
Sabin Delivers Ebola Sudan Vaccine to Fight Outbreak in Uganda
Sabin Vaccine Institute was the first organization to provide the World Health Organization (WHO) its Ebola Sudan vaccine to help with the Ebola Sudan outbreak in Uganda. Approximately 1,100 doses of Sabin’s vaccine were sent to Uganda.
Read the full report
See our impact through infographics, stories and statistics.
We make vaccines more accessible, enable innovation and expand immunization across the globe.